Making Sense of Project Impact: Preclinical testing As part of our effort to raise awareness during Childhood Cancer Awareness Month, we created an infographic about our newest initiative that aims to get new and better treatments to children with brain tumors: Project Impact. Today, we want to spend some time talking about a major piece of that initiative, the so-called “preclinical testing […] September 29, 2014
Project Impact Gets to Work: Removing Barriers to Pediatric Cancer Treatments The choice of when to push change in a broken system, “depends largely on timing, opportunity, and the leverage of the people initiating the change,[1]” according to popular theories in system change. Moreover, to achieve systems change leaders must, “bring people addressing parts of the problem around the same table,” and by “…inviting new people […] March 27, 2014
Introducing the Jumpstarting Brain Tumor Drug Development Coalition We first told you about our Clinical Trial Endpoints Initiative back in late June of 2013. We then let the Chair of the Initiative’s Steering Committee, Dr. Patrick Wen of Dana-Farber Cancer Institute, explain the promise of this effort further in a video interview we posted back in December. Now, we’d like to introduce you […] January 28, 2014
Because of You: Closing Out a Fruitful 2013 in Brain Tumor Research The brain tumor community is dedicated to fighting one of the toughest battles imaginable. Thus we are all – from patients, to caregivers, to doctors, to scientists, to advocates – constantly looking forward to the next hurdle we have to jump on our mission toward a cure. Here at the National Brain Tumor Society, specifically, […] December 30, 2013
Advancing Research to Therapies Conference Connects Field National Brain Tumor Society hosted the inaugural Advancing Research to Therapies (ART) for Brain Tumors Conference in Washington, D.C. during Brain Tumor Awareness Month in May 2013. The ART Conference brought together more than 100 leading experts from academic research labs, government agencies, biotech and pharmaceutical companies, and venture capital firms to discuss faster commercialization […] July 23, 2013